☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - November 2023

The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines.

Progesterone vaginal capsules (Utrogestan®) has been rejected for use in the prevention of preterm birth in women with a singleton pregnancy who have a short cervix and/or a history of spontaneous preterm birth. The manufacturer failed to make a submission for this indication.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - November 2023' by emailShare 'SMC Update - November 2023' on FacebookShare 'SMC Update - November 2023' on TwitterShare 'SMC Update - November 2023' on MastodonShare 'SMC Update - November 2023' on LinkedInShare 'SMC Update - November 2023' on reddit

No Comments to “SMC Update - November 2023”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.